Загрузка...
Chimeric Antigen Receptor Therapy for Cancer
Improved outcomes for patients with cancer hinge on the development of new targeted therapies with acceptable short-term and long-term toxicity. Progress in basic, preclinical, and clinical arenas spanning cellular immunology, synthetic biology, and cell-processing technologies has paved the way for...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4120077/ https://ncbi.nlm.nih.gov/pubmed/24274181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1146/annurev-med-060512-150254 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|